Hypothetical risk ratio | Specificity (%) | Incidence peripheral neuropathy | True GBS risk ratio a | Expected observed risk ratio b | PFP c (%) | Number of false positive GBS cases |
---|---|---|---|---|---|---|
1 | 100.0 | 3.3/10,000 | 1.00 | 1.00 | 0.0 | 0 |
1 | 91.7 | Â | Â | Â | 54.5 | 454 |
1 | 88.9 | Â | Â | Â | 62.4 | 631 |
1 | 80.6 | Â | Â | Â | 75.2 | 1153 |
5 | 100.0 | 3.3/10,000 | 1.29 | 1.29 | 0.0 | 0 |
5 | 91.7 | Â | Â | 1.18 | 40.7 | 414 |
5 | 88.9 | Â | Â | 1.16 | 49.4 | 591 |
5 | 80.6 | Â | Â | 1.12 | 64.8 | 1113 |
10 | 100.0 | 3.3/10,000 | 1.47 | 1.47 | 0.0 | 0 |
10 | 91.7 | Â | Â | 1.33 | 29.2 | 364 |
10 | 88.9 | Â | Â | 1.30 | 37.9 | 540 |
10 | 80.6 | Â | Â | 1.23 | 54.6 | 1063 |
1 | 100.0 | 5.6/10,000 | 1.00 | 1.00 | 0.0 | 0 |
1 | 91.7 | Â | Â | Â | 68.4 | 822 |
1 | 88.9 | Â | Â | Â | 74.7 | 1122 |
1 | 80.6 | Â | Â | Â | 84.1 | 2012 |
5 | 100.0 | 5.6/10,000 | 1.29 | 1.29 | 0.0 | 0 |
5 | 91.7 | Â | Â | 1.14 | 56.4 | 782 |
5 | 88.9 | Â | Â | 1.12 | 64.2 | 1082 |
5 | 80.6 | Â | Â | 1.08 | 76.5 | 1971 |
10 | 100.0 | 5.6/10,000 | 1.47 | 1.47 | 0.0 | 0 |
10 | 91.7 | Â | Â | 1.27 | 45.3 | 731 |
10 | 88.9 | Â | Â | 1.24 | 53.8 | 1032 |
10 | 80.6 | Â | Â | 1.17 | 68.5 | 1921 |